RT Journal
A1 Hampton T
T1 NEw therapies for gi cancers fall short
JF JAMA
JO JAMA
YR 2009
FD July 22
VO 302
IS 4
SP 373
OP 374
DO 10.1001/jama.2009.1021
UL http://dx.doi.org/10.1001/jama.2009.1021
AB 
Results from several large clinical trials on cancers of the colon, rectum, and anus have failed to fulfill hopes for better treatments. Findings presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), held May 29 through June 2 in Orlando, indicate that in most cases, the current standards of care should remain the treatments of choice. However, one potentially practice-changing trial suggested that many patients with advanced colorectal cancer can forgo standard surgery and receive chemotherapy as first-line care.